Navigating Crypto Volatility: All Options Considered
In this edition of the All Options Considered podcast, BI's Chief Global Derivatives Strategist Tanvir Sandhu is joined by Dan Tapiero, Founder & CEO of 10T Holdings & 1RoundTable Partners, to discuss how to navigate the volatility of digital assets. All Options Considered is part of the FICC Focus podcast. Listen to FICC Focus on Apple Podcasts and Spotify. Apple: https://podcasts.apple.com/gb/podcast/ficc-focus/id1589459799 Spotify: https://open.spotify.com/show/00X0l59Bw9RMRMyKdsLk0H?si=1a91eb80735c496e
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Entrepreneur
12 minutes ago
- Entrepreneur
6 Things to Remember When Pressure Is High and Morale Is Low
These are uncertain and unstable times. Over the last year, organizations of all sizes have experienced layoffs or been adversely affected by rising prices. Employees at all levels, from entry-level to senior executives, are anxious or unsure about the future and unable to predict how economic and political pressures will impact them. If this sounds familiar, and you're grappling with how to best lead, here are six things to remember. Related: How to Lead Effectively When Everything Feels Fragile and Nothing Feels Certain
Yahoo
24 minutes ago
- Yahoo
L'Oréal acquires a majority stake in British skincare brand Medik8
L'Oréal has acquired a majority stake in the UK's Medik8 as it seeks to expand its position in the skincare market, the French beauty giant confirmed on Monday. As part of the deal, private equity firm Inflexion will remain a minority shareholder, and the current management committee will also stay in their roles. The cost of the stake is officially undisclosed, although the Financial Times reported last week that the potential deal was worth around €1bn. L'Oréal's share price was roughly unchanged on the news. 'We are delighted to welcome Medik8 to the L'Oréal family,' said Cyril Chapuy, President of L'Oréal LUXE. 'As a premium skincare range, with high levels of proven efficacy at an accessible price point, Medik8 perfectly complements our existing skincare portfolio,' he added. L'Oréal has been seeking to capitalise on the boom in science-driven skincare, partly driven by social media influencers. Brands already under its 'Dermatological Beauty Division' include La Roche-Posay, Cerave, Vichy, Skinceuticals, and Skinbetter Science. Related L'Oréal acquires Galderma stake and targets the injectables market The Body Shop goes into administration, with hundreds of UK jobs at risk This unit brought in over €7bn in revenue in 2024, representing an almost 10% year-on-year rise, making it L'Oréal's fastest-growing division. Seeking to expand its portfolio, L'Oréal bought soap maker Aesop in 2023, and Korean beauty brand Dr.G in December. Last year, L'Oréal also acquired a 10% stake in skincare firm Galderma, as well as acquiring the beauty licence for Miu Miu. At the time of the Galderma deal, the French firm said it was 'increasingly investing in a more holistic approach, spanning the entire beauty routine' — thereby 'anticipating and intercepting the signs of skin ageing'. Medik8, founded in 2009, specialises in anti-ageing treatments and was bought by UK-based private equity firm Inflexion in 2021. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Bloomberg
an hour ago
- Bloomberg
Barclays Cuts More Than 200 Investment Bank Jobs to Reduce Costs
Barclays Plc is preparing to cut more than 200 jobs in its investment bank in the coming days as part of Chief Executive Officer C.S. Venkatakrishnan's plan to boost the profitability of the division. Staffers in investment banking, global markets and research will likely be affected, according to people familiar with the matter, who asked not to be named discussing personnel. Managing directors will be the most senior roles affected, they added. The reduction represents about 3% of the investment bank's headcount.
